Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group.
Katzenstein DA, Hughes M, Albrecht M, Hammer S, Para M, Murphy R, Valdez H, Haubrich R, Liou S. Katzenstein DA, et al. Among authors: murphy r. AIDS Res Hum Retroviruses. 2000 Jul 20;16(11):1031-7. doi: 10.1089/08892220050075282. AIDS Res Hum Retroviruses. 2000. PMID: 10933617 Clinical Trial.
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Wheat J, Hafner R, Wulfsohn M, Spencer P, Squires K, Powderly W, Wong B, Rinaldi M, Saag M, Hamill R, Murphy R, Connolly-Stringfield P, Briggs N, Owens S; National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators. Wheat J, et al. Among authors: murphy r. Ann Intern Med. 1993 Apr 15;118(8):610-6. doi: 10.7326/0003-4819-118-8-199304150-00006. Ann Intern Med. 1993. PMID: 8383934 Clinical Trial.
Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection.
Wallace MR, Moss RB, Beecham HJ 3rd, Grace CJ, Hersh EM, Peterson E, Murphy R, Shepp DH, Siegal FP, Turner JL, Safrin S, Carlo DJ, Levine AM. Wallace MR, et al. Among authors: murphy r. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):358-62. doi: 10.1097/00042560-199608010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8673544 Clinical Trial.
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J Jr, Stool E, Jemsek JG, Dellamonica P, Cross A, Dunkle L. Spruance SL, et al. Among authors: murphy r. Ann Intern Med. 1997 Mar 1;126(5):355-63. doi: 10.7326/0003-4819-126-5-199703010-00003. Ann Intern Med. 1997. PMID: 9054279 Clinical Trial.
Safety, pharmacokinetics, and efficacy of (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine with efavirenz and stavudine in antiretroviral-naïve human immunodeficiency virus-infected patients.
Herzmann C, Arastèh K, Murphy RL, Schulbin H, Kreckel P, Drauz D, Schinazi RF, Beard A, Cartee L, Otto MJ. Herzmann C, et al. Among authors: murphy rl. Antimicrob Agents Chemother. 2005 Jul;49(7):2828-33. doi: 10.1128/AAC.49.7.2828-2833.2005. Antimicrob Agents Chemother. 2005. PMID: 15980356 Free PMC article. Clinical Trial.
4,586 results